European Green Transition (AIM: EGT), a company seeking to acquire and transform revenue stage businesses supporting the green energy transition in Europe, announces that it has entered into an exclusive
European Green Transition (AIM: EGT) Appointment of Independent Non-Executive Director
European Green Transition (AIM: EGT), a company seeking to acquire and transform revenue stage businesses supporting the green energy transition in Europe, announces the appointment of Mick Kearney as an
Traders Cafe with Zak Mir: Bulletin Board Heroes, Monday 13th October 2025
Zak Mir takes a charting look at some of the most closely followed small caps on the London Stock Exchange. Today’s charts are FTSE 100, DAX, Dow, Bitcoin, Ethereum, Gold,
European Green Transition: From Exploration to Execution at The Investor Summit
A Company in Transition
European Green Transition (AIM: EGT) Interim results and M&A strategy update
European Green Transition (AIM: EGT), a company which aims to capitalise on the opportunities created by the green energy transition in Europe, announces its unaudited results for the six months
hVIVO plc – Unaudited Interim Results for Six Months Ended 30 June 2025
Interim results Trading in line with expectations for full year Returning to growth in 2026
European Green Transition: From Exploration to Execution at The Investor Summit
A Company in Transition
RNS Hotlist with Zak Mir: RR, HVO, SWC, TERN, HAMA, CHLL, AOM, GSCU, SATS, ECO, CRTX, RBW, VAL, PRD & WCAT
(Alliance News) – Rolls-Royce Holdings (RR.) is speaking with advisers about funding options for its small nuclear reactor business, which could include an initial public offer of shares, the Financial Times
hVIVO plc (AIM: HVO) Appointment of Non-Executive Chair
hVIVO plc (AIM: HVO), a full-service Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, confirms that, further to its announcement on 29 July 2025, Shaun
hVIVO plc (AIM: HVO) Proposed appointment of Chair
hVIVO plc (AIM: HVO), a full-service Contract Research Organisation and the world leader in human challenge clinical trials, announces the appointment of Shaun Chilton as Non-Executive Chair, subject to successful completion of
hVIVO PLC (AIM:HVO) Notice of Trading Update
hVIVO plc (AIM: HVO), a full-service Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, confirms that it will issue a trading update for the six months ended 30
hVIVO PLC (AIM:HVO) Positive results from client Phase 2b field study
Positive topline results from client Phase 2b field study